AI Verdict
GBDC has stronger fundamentals based on our AI analysis.
GBDC vs GANX Fundamental Comparison
| Metric | GBDC | GANX |
|---|---|---|
| Revenue | N/A | $305,239.0 |
| Net Income | $65.2M | $-15.6M |
| Net Margin | N/A | -5,118.5% |
| ROE | 1.7% | -264.4% |
| ROA | 0.7% | -142.4% |
| Current Ratio | N/A | 2.52x |
| Debt/Equity | 1.25x | 0.07x |
| EPS | $0.25 | $-0.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GBDC vs GANX: Frequently Asked Questions
Is GBDC or GANX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GBDC has stronger fundamentals. GBDC is rated HOLD (62% confidence) while GANX is rated STRONG SELL (92% confidence). This is not investment advice.
How does GBDC compare to GANX fundamentally?
GOLUB CAPITAL BDC, Inc. has ROE of 1.7% vs Gain Therapeutics, Inc.'s -264.4%. Net margins are N/A vs -5,118.5% respectively.
Which stock pays higher dividends, GBDC or GANX?
GBDC has a dividend yield of N/A or no dividend while GANX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GBDC or GANX for long term?
For long-term investing, consider that GBDC has HOLD rating with 62% confidence, while GANX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GBDC vs GANX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GBDC vs GANX, the AI consensus favors GBDC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.